An auditable protocol for treating attention deficit/hyperactivity disorder.
We present an auditable protocol for attention deficit/hyperactivity disorder (ADHD) or hyperkinetic disorder. The protocol is derived from standard recommendations and evidence, and is intended for outpatient medical clinic practice in secondary care. Suggested side effect rating scales are included.
Hill
P
P
Great Ormond Street Hospital for Children, London WC1N 3JH, UK. strandend@dial.pipex.com
Taylor
E
E
D000465:Algorithms; D001289:Attention Deficit Disorder with Hyperactivity / Q000628:therapy*; D002648:Child; D002985:Clinical Protocols / Q000592:standards; D002986:Clinical Trials as Topic; D006801:Humans; D006948:Hyperkinesis / Q000628:therapy*; D007099:Imipramine / Q000627:therapeutic use; D008485:Medical Audit; D008774:Methylphenidate / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000627:therapeutic use; D017211:Treatment Failure
D011619:Psychotropic Drugs; D008774:Methylphenidate; D007099:Imipramine